Search
for
Sort by
Research 91–120 of 117
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Crisaborole as a Potential Treatment for Pediatric Alopecia Areata: A Case Report and Literature Review
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- A retrospective review of paediatric alopecia areata cases seen in a tertiary institution in Singapore
- Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification
- Effect of camouflaging agents on psychologic well-being: A cross-sectional survey of hair loss patients
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Comment on ‘Androgenetic alopecia is associated with increased scalp hardness’: role of phosphodiesterase inhibitors?
- Novel drugs of United States Food and Drug Administration approved in 2024
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Common Skin Disorders in Pediatric Skin of Color
- The association of medications and supplements with human male reproductive health: a systematic review
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Heterozygous Variants of the SLC39A4 Gene and Possible Increased Risk for Developing Acrodermatitis Enteropathica with Kaposi’s Varicelliform Eruption
- Update From Dermatology Nurses’ Association Convention 2025
- Efficacy and Safety of Tofacitinib in Paediatric Alopecia Aerata - A Prospective Observational Study
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology